logo
ENTITY

Alaunos Therapeutics (TCRT US)

1
Analysis
Health Care • United States
Alaunos Therapeutics Inc. operates as a clinical stage cellular immuno-oncology company. The Company focuses on the treatment of solid tumors through adoptive TCR-T cell therapy. Alaunos Therapeutics serves customers worldwide.
more
Exchange Announcement • 14 Nov 2024 22:30

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Exchange Announcement • 10 Oct 2024 20:30

Current Report (Form 8-K | Period ending 2024-10-04)

Exchange Announcement • 15 Aug 2024 04:54

Quarterly Report (Form 10-Q | Period ending 2024-06-30)

Exchange Announcement • 16 Jul 2024 21:02

Current Report (Form 8-K | Period ending 2024-07-16)

Exchange Announcement • 16 Jul 2024 21:00

Current Report (Form 8-K | Period ending 2024-07-16)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x